These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2688815)

  • 21. Novel erythropoiesis-stimulating agents: a new era in anemia management.
    Macdougall IC
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):200-7. PubMed ID: 18077782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical applications of erythropoietin].
    Robak T
    Acta Haematol Pol; 1994; 25(2 Suppl 1):112-23. PubMed ID: 8067196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of anaemia in haemodialysis patients with recombinant erythropoietin.
    Winearls CG
    Nephron; 1989; 51 Suppl 1():26-8. PubMed ID: 2915779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis. Secondary effects of the increase of haemoglobin.
    Zehnder C; Glück Z; Descoeudres C; Uehlinger DE; Blumberg A
    Nephrol Dial Transplant; 1988; 3(5):657-60. PubMed ID: 3146724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Erythropoietin--the first hematologic hormone in clinical use].
    Rhyner K
    Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
    Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
    Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency].
    Marisavljević D; Djukanović Lj; Lezajić V
    Srp Arh Celok Lek; 1992; 120(9-10):281-5. PubMed ID: 1306020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of renal anemia with recombinant human erythropoietin].
    Burghard R; Gordjani N; Leititis JU
    Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of anemia in patients with renal failure using erythropoietin obtained by genetic recombination].
    Wiecek A; Kokot F; Grzeszczak W; Klin M
    Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):782-6. PubMed ID: 2095546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
    Salim KA; Salim S; Mathew T
    J Assoc Physicians India; 1992 Jan; 40(1):42-3. PubMed ID: 1634463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].
    Stutz B; Rhyner K; Vögtli J; Binswanger U
    Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seizures in haemodialysis patients treated with recombinant human erythropoietin.
    Edmunds ME; Walls J; Tucker B; Baker LR; Tomson CR; Ward M; Cunningham J; Moore R; Winearls CG
    Nephrol Dial Transplant; 1989; 4(12):1065-9. PubMed ID: 2517327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of recombinant erythropoietin therapy for renal transplantation.
    Ward HJ
    Am J Nephrol; 1990; 10 Suppl 2():44-7; discussion 48-52. PubMed ID: 2260618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of erythropoiesis under the influence of recombinant human erythropoietin (R-EPO) in dialyzed patients].
    Debska-Slizień A; Kabata J; Rutkowski B; Ciesielski D; Jankowska-Gan E; Manitius A
    Pol Arch Med Wewn; 1991 Jun; 85(6):341-51. PubMed ID: 1896397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anemia in hemodialysis patients.
    Higgins MR; Grace M; Ulan RA; Silverberg DS; Bettcher KB; Dossetor JB
    Arch Intern Med; 1977 Feb; 137(2):172-6. PubMed ID: 836115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.
    Howarth JE; Waters HM; Shanks D; Hyde K; Yin JA; Geary CG; Anastassiades E; Howarth D; Gokal R
    J Clin Pathol; 1993 Jan; 46(1):41-4. PubMed ID: 8432886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
    Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.